Open access
Sep 2026
Impulse control symptoms associated with aripiprazole long-acting injectable: A prospective cohort study
Impulse control disorders (ICDs) have been described in association with dopamine partial agonists, particularly aripiprazole. However, data regarding the risk of ICDs with long-acting injectable (LAI) formulations remain limited. To prospectively examine the presence and course of impulse control symptoms i...
Francisco José López García, Guido de Marco Galliano, Melisa Darlene López Soto et al.
· Therapeutic Advances in Psyc... · 0 citations